Literature DB >> 16787284

Chemical and structural diversity of siRNA molecules.

Barbara Nawrot1, Katarzyna Sipa.   

Abstract

Short interfering RNAs (siRNAs) are 21-23 nt long double-stranded oligoribonucleotides which in mammalian cells exhibit a potency for sequence-specific gene silencing via an RNA interference (RNAi) pathway. It has been already proven that exogenous, chemically synthesized siRNA molecules are effective inhibitors of gene expression and are widely applied for analysis of protein function and proteomics-based target identification. Moreover, since their discovery siRNA molecules have been implemented as potential candidates for therapeutic applications. Variously modified siRNA molecules containing sugar modifications (2'-OMe, -F, -O-allyl, -amino, orthoesters and LNA analogues), internucleotide phospodiester bond modifications (phosphorothioates, boranophosphates), base modifications (s(2)U) as well as 3'-terminal cholesterol-conjugated constructs were investigated as potential candidates for effective inhibition of gene expression. This chapter reviews an impact of chemical and structural modifications of siRNA molecules on their serum and thermal stability, cellular and in vivo activity, cellular uptake, biodistribution and cytotoxicity. Functional analysis of chemically modified siRNA molecules allows for better understanding of the mechanism of the RNA interference process as well as demonstrates immense efforts in optimizing in vivo potency of siRNA molecules for RNAi-based drug design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787284     DOI: 10.2174/156802606777303658

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  13 in total

1.  Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA.

Authors:  Katarzyna Sipa; Elzbieta Sochacka; Julia Kazmierczak-Baranska; Maria Maszewska; Magdalena Janicka; Genowefa Nowak; Barbara Nawrot
Journal:  RNA       Date:  2007-06-21       Impact factor: 4.942

2.  Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs.

Authors:  Michael A Collingwood; Scott D Rose; Lingyan Huang; Chris Hillier; Mohammad Amarzguioui; Merete T Wiiger; Harris S Soifer; John J Rossi; Mark A Behlke
Journal:  Oligonucleotides       Date:  2008-06

3.  Gene silencing activity of siRNA molecules containing phosphorodithioate substitutions.

Authors:  Xianbin Yang; Malgorzata Sierant; Magdalena Janicka; Lukasz Peczek; Carlos Martinez; Tom Hassell; Na Li; Xin Li; Tianzhi Wang; Barbara Nawrot
Journal:  ACS Chem Biol       Date:  2012-04-26       Impact factor: 5.100

4.  Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs.

Authors:  Qing Ge; Anne Dallas; Heini Ilves; Joshua Shorenstein; Mark A Behlke; Brian H Johnston
Journal:  RNA       Date:  2009-11-30       Impact factor: 4.942

5.  Significance of stereochemistry of 3'-terminal phosphorothioate-modified primer in DNA polymerase-mediated chain extension.

Authors:  Barbara Nawrot; Natasha Paul; Beata Rebowska; Wojciech J Stec
Journal:  Mol Biotechnol       Date:  2008-09-04       Impact factor: 2.695

6.  MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity.

Authors:  John J Turner; Simon W Jones; Sterghios A Moschos; Mark A Lindsay; Michael J Gait
Journal:  Mol Biosyst       Date:  2006-11-20

7.  Specific Silencing of L392V PSEN1 Mutant Allele by RNA Interference.

Authors:  Malgorzata Sierant; Alina Paduszynska; Julia Kazmierczak-Baranska; Benedetta Nacmias; Sandro Sorbi; Silvia Bagnoli; Elzbieta Sochacka; Barbara Nawrot
Journal:  Int J Alzheimers Dis       Date:  2011-04-07

8.  Inhibition of MDR1 expression with altritol-modified siRNAs.

Authors:  Michael Fisher; Mikhail Abramov; Arthur Van Aerschot; Dong Xu; Rudolph L Juliano; Piet Herdewijn
Journal:  Nucleic Acids Res       Date:  2007-01-30       Impact factor: 16.971

Review 9.  Achieving HIV-1 Control through RNA-Directed Gene Regulation.

Authors:  Vera Klemm; Jye Mitchell; Christina Cortez-Jugo; Francesca Cavalieri; Geoff Symonds; Frank Caruso; Anthony Dominic Kelleher; Chantelle Ahlenstiel
Journal:  Genes (Basel)       Date:  2016-12-07       Impact factor: 4.096

10.  EphA4 Negatively Regulates Myelination by Inhibiting Schwann Cell Differentiation in the Peripheral Nervous System.

Authors:  Ruyue Chen; Xiaoming Yang; Bin Zhang; Shengran Wang; Shuangxi Bao; Yun Gu; Shiying Li
Journal:  Front Neurosci       Date:  2019-11-13       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.